Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS. - Wikidata - awgldk - TriplyDB

Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS.

Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS.

http://www.wikidata.org/entity/Q36589374

about

A periodic table for cancer Overview and management of dermatologic events associated with targeted therapies for medullary thyroid cancer The role of Cdk5 in neuroendocrine thyroid cancer Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis My, How Things Have Changed in Multiple Endocrine Neoplasia Type 2A!Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma.Molecular approaches to thyroid cancer diagnosis.Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke.Recombinant leukemia inhibitory factor suppresses human medullary thyroid carcinoma cell line xenografts in mice.Molecular diagnosis and comprehensive treatment of multiple endocrine neoplasia type 2 in Southeastern Chinese TET proteins and the control of cytosine demethylation in cancer.Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells.Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer Selective Mitochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival In Vitro and In Vivo Mitochondria-targeted nitroxide, Mito-CP, suppresses medullary thyroid carcinoma cell survival in vitro and in vivo.Development and clinical application of an integrative genomic approach to personalized cancer therapy Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma.A differential diagnosis of inherited endocrine tumors and their tumor counterparts Exomic sequencing of four rare central nervous system tumor types Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer.Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma.Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations.Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma.The Role of STAT3 in Thyroid Cancer.Translational research in endocrine surgery.Medullary thyroid carcinoma: a 25-year perspective.Bioinformatics in otolaryngology research. Part one: concepts in DNA sequencing and gene expression analysis.Advances in thyroid cancer treatment: latest evidence and clinical potential.Selective use of vandetanib in the treatment of thyroid cancer.Thyroid C-Cell Biology and Oncogenic Transformation.Medullary Thyroid Cancer: Clinical Characteristics and New Insights into Therapeutic Strategies Targeting Tyrosine Kinases.Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells.Targeted Therapies in Thyroid Cancer: An Extensive Review of the Literature.Putative BRAF activating fusion in a medullary thyroid cancer.Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma.Oncogenesis of Thyroid Cancer Skewed mutational spectrum of RET proto-oncogene Exon10 in Iranian patients with medullary thyroid carcinoma.The genomic landscape of phaeochromocytoma.

P2860

Q26858878-7652AD25-AC1D-4BD7-90C7-8A71CBFBB04E Q27005701-A3198B53-E328-4DCF-A38A-27D8F77CA309 Q28392185-4432F613-D941-4499-BBC7-5408731380A5 Q28397935-354A50AA-D6F4-41CF-96C2-91863B7F9061 Q33570313-52479FAC-B72F-4746-A466-8A28D1FD49E8 Q33587821-94E64D6B-C1FE-4C41-A18A-C98F16682A08 Q33813776-EA14FDE2-45DB-4939-A55B-86B3BE2A81B5 Q34160828-7219DFA0-17A1-4DB0-8AFE-E772465CDDD5 Q34468665-3443463E-7D34-4075-A42D-45286CB16B10 Q34749417-4C577FE0-F3AB-4877-8D3F-35BF61BC9DE2 Q34821265-93805C53-12E8-40ED-BC63-AAA03EA51D63 Q35016357-A55F420C-863A-4289-9C61-2BA70D22DC37 Q35021377-9500D735-6E0D-4479-B021-E151BF25B8A2 Q35672203-356FBAE0-9969-4491-B38B-56D1FAF7A576 Q35752400-EB218B5A-41F3-4A01-8A9A-A04EBB9B00F2 Q36489199-D0A8866E-00DE-46CD-A0AC-D6B1C2DD801C Q36736460-597F1AA7-D17A-40E8-AE4A-71B754C45BC0 Q36954557-24F7C2A7-8341-4C13-80DF-4A658E172472 Q37009001-2E7B4136-6F07-42BE-876C-0A4848A38A49 Q37023603-D9220908-A847-4322-B8F6-3D6EEAA3CECC Q37038397-406E7472-B2AC-4DEC-837C-C82EE7C9686B Q37179234-28D9ACD6-78EB-4354-BE79-A1A4E7838BCE Q37225274-B78A7F95-4644-4C15-853D-0FCB5550C2B6 Q37633558-D5881AAF-FA7F-4AD5-A027-77B0694CEA61 Q37688417-A03742EA-16DA-40E4-B770-1AC2A3440827 Q37693498-F7F34BB2-CDD3-4D3B-A724-6E3BB8EC668C Q38135137-8738959C-8948-4290-B917-7DB0AA24C466 Q38171726-99B1445F-7370-41CF-93AE-146AA2619C5A Q38250064-475A7ED6-8837-4631-92F5-090F9D73407F Q38305056-B8E0810E-BE7A-45A0-920D-2A0B313031A9 Q38546474-B6FCD5F1-0AD9-43D7-94F1-F38526A550E0 Q38614485-7E3DA59B-79A3-4EA0-860F-B6024BF4E770 Q38683133-29750BF4-9ADC-4AC5-B99D-CFB448C51720 Q38802314-3C3F4687-52AF-4612-AE64-0E4B49DA168A Q38883187-B1E3856E-51FD-4BA9-8D20-F81912406D5E Q40776672-661BB3E9-66CC-4C24-92C2-E6D8646C25CC Q41251561-85D0DF3D-4C58-4C01-80B9-306890C1EA2B Q41381572-1D228F81-9394-4884-870D-E8A8D203CD3E Q41397485-E6D50791-1C59-4D4B-ADEB-57249B35E855 Q41643771-91F4F6C3-25CC-40BD-BB7A-D5951802E5C9

P2860

Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS.

http://www.wikidata.org/entity/Q36589374

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Exomic sequencing of medullary ...... enic mutations in RET and RAS.

@ast

Exomic sequencing of medullary ...... enic mutations in RET and RAS.

@en

type

label

Exomic sequencing of medullary ...... enic mutations in RET and RAS.

@ast

Exomic sequencing of medullary ...... enic mutations in RET and RAS.

@en

prefLabel

Exomic sequencing of medullary ...... enic mutations in RET and RAS.

@ast

Exomic sequencing of medullary ...... enic mutations in RET and RAS.

@en

P1433

Q36589374-2925390E-7D3A-4380-BF28-2EF2A22F2601

P1476

Q36589374-BB4AD4CC-837F-42BF-804D-29318B9B390B

P2093

Q36589374-09603C67-3178-42BC-8E48-2E003F89FCC7

Q36589374-0DA7F911-DC6E-4C36-9A88-0368573F99CE

Q36589374-11862A02-6072-4860-96A0-B8AF9E94C6EB

Q36589374-1454DEC9-66F6-484B-9FD3-9B3BFE011470

Q36589374-1C7A6750-EA79-4005-AC50-9B00CFD12B97

Q36589374-295B8D9D-4378-4B32-AEB1-DF014170284D

Q36589374-3D15C450-D5E0-453D-BB2E-ED57308DB8C7

Q36589374-4C26B85B-A7E4-4BAC-8A83-F930CD64CD8C

Q36589374-5157682D-DC60-4545-9E00-33BF6885AE4B

Q36589374-60DE3EBF-3080-4815-B9E6-D83FDF244352

P2860

Q36589374-018847A4-5075-413A-946A-417DEE41F968

Q36589374-02D24070-348F-44B2-9302-E000FDAA7811

Q36589374-1042BE39-4180-4C0C-95AB-10994BA76AC0

Q36589374-12F294F1-DCA2-4EB3-928D-59FBFD19A8D7

Q36589374-1FC3A9D2-BEDC-48C5-98AF-60CBC458EBB0

Q36589374-206B9BB0-D98B-4D5F-8089-FB4B12294DC4

Q36589374-22F2F779-46B4-4AE9-A943-0CE5174D6736

Q36589374-2463347B-651F-4A92-B4E4-D5F359BAD38E

Q36589374-254A3E1F-B25E-4DD0-BEC0-11A9325D571A

Q36589374-270B5572-A514-462F-A9FE-B77618E48877

P304

Q36589374-BC3A5763-8499-4C9F-8915-78DCF503330E

P31

Q36589374-C43B777A-0042-45B8-AA07-AEF56AD8D80C

P356

Q36589374-F9B5BE7A-9171-4F5E-A8E1-9767B3D957AE

P407

Q36589374-37DEC1D0-DCB4-48CB-BF42-4FB13B23F76E

P433

Q36589374-5247ED4B-FE15-4CF8-AE14-300A846906FC

P478

Q36589374-888B8E7F-57B6-4721-96E5-27D078DF0DF4

P50

Q36589374-13F9B637-587E-4F76-96DF-24651038EB27

Q36589374-460D216F-0895-44A6-94EB-3EBF08BB850C

Q36589374-717E3C29-4F62-4255-AD33-CFF237191929

Q36589374-961E261C-C133-4D3D-944C-11B363A401A5

Q36589374-F7C3E3F9-CA51-4B27-80E2-01E162DF9643

Q36589374-FBCB2D8D-95E0-4E6B-9452-FD75C069D0C8

P577

Q36589374-085C97F9-74F0-4A6F-BAC2-702243DB0292

P5875

Q36589374-13445150-02A0-4769-908C-E47880F5B0B8

P698

Q36589374-5594BCA5-BD11-4578-BF53-BDCCA00DF10C

P932

Q36589374-934B64B6-A9E0-4825-A9CE-9C42E8D15BA8

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Exomic sequencing of medullary ...... enic mutations in RET and RAS.

@en

P2093

Allen S Ho

http://www.w3.org/2001/XMLSchema#string

Barry D Nelkin

http://www.w3.org/2001/XMLSchema#string

Bruce Robinson

http://www.w3.org/2001/XMLSchema#string

Chetan Bettegowda

http://www.w3.org/2001/XMLSchema#string

Douglas W Ball

http://www.w3.org/2001/XMLSchema#string

James A Fagin

http://www.w3.org/2001/XMLSchema#string

Justin Bishop

http://www.w3.org/2001/XMLSchema#string

Laura D Wood

http://www.w3.org/2001/XMLSchema#string

Luc G T Morris

http://www.w3.org/2001/XMLSchema#string

Mark Sausen

http://www.w3.org/2001/XMLSchema#string

P2860

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

An integrated genomic analysis of human glioblastoma multiforme

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.

Cancer statistics, 2012

The consensus coding sequences of human breast and colorectal cancers

The genomic landscapes of human breast and colorectal cancers

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

P304

E364-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2012-2703

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P50

Ralph H. Hruban

Kenneth W Kinzler

Nicholas J Roberts

Victor Velculescu

Bert Vogelstein

P577

2012-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233977451

http://www.w3.org/2001/XMLSchema#string

P698

23264394

http://www.w3.org/2001/XMLSchema#string

P932

3565108

http://www.w3.org/2001/XMLSchema#string